EX-99 2 dex99.htm PRESS RELEASE Press release

Exhibit 99

Patterson Companies Reports Improved Fourth Quarter Operating Results

St. Paul, MN—May 24, 2007—Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated sales of $739,143,000 for the fourth quarter of fiscal 2007 ended April 28, an increase of 6% from $695,177,000 in the year-earlier quarter. On a comparable basis, which excludes the telemarketing operation of the former Accu-Bite business that was closed in early May 2006, consolidated sales increased approximately 8%. Net income came to $59,924,000 or $0.44 per diluted share, up 6% from $56,819,000 or $0.41 per diluted share in the fourth quarter of fiscal 2006. Current quarter earnings included stock compensation expense of approximately $0.01 per diluted share.

Consolidated fourth quarter sales were consistent with Patterson’s expectations. Earnings for this period were affected by a reduced dental gross margin due primarily to under-plan sales of high-margin software.

For full-year fiscal 2007, consolidated sales increased 7% to $2,798,398,000 from $2,615,123,000 in fiscal 2006. Net income of $208,336,000 or $1.51 was up 5% from $198,423,000 or $1.43 per diluted share, in fiscal 2006. Fiscal 2007 earnings included stock compensation expense of approximately $0.05 per diluted share.

Sales of Patterson Dental, Patterson’s largest business, reported comparable basis sales growth of approximately 6% to $542,573,000 in the fourth quarter or 4% when Accu-Bite’s telemarketing sales are included.

 

   

Sales of consumable dental supplies and printed office products increased approximately 6% on a comparable basis from last year’s fourth quarter or 2% on an as-reported basis.

 

   

Total sales of dental equipment increased 4% in the fourth quarter. Sales of basic dental equipment rose a stronger than anticipated 13%, which included a solid contribution from digital radiography systems. As previously forecasted, year-over-year sales of CEREC 3D® dental restorative systems declined as some significant product enhancements, introduced at the end of the third quarter, were transitioned into the marketplace.

 

   

Sales of other services and products, consisting primarily of technical service parts and labor, software support services and artificial teeth increased 14% in the fourth quarter.

Sales of the Webster Veterinary unit increased 13% in the fourth quarter of fiscal 2007 to $109,687,000. Sales of Patterson Medical, Patterson’s rehabilitation supply and equipment unit, increased 16% in the fourth quarter to $86,883,000 in comparison to the year-earlier level. Excluding the impact of three acquisitions related to the unit’s branch office strategy and foreign currency translations, fourth quarter sales of Patterson Medical rose approximately 8%.

James W. Wiltz, president and chief executive officer, commented: “Total dental sales generally met our expectations, paced by solid sales of consumable supplies and a rebound in sales of basic dental equipment. As expected, CEREC sales declined during the process of rolling out several important new enhancements to this product line. New CEREC software results in significantly greater ease of use, while a new optional milling chamber provides for faster crown milling times. Customer interest in CEREC units equipped with these features has been encouraging, and we believe CEREC sales should strengthen in fiscal 2008.”

He continued: “Patterson’s veterinary business recorded another strong performance in the fourth quarter due to the continued growth of its consumables business and a 60% increase in sales of equipment and IntraVet practice management software. Webster’s strategic emphasis on expanding its value-added platform, which encompasses its equipment and software initiatives, is clearly starting to pay dividends. We also are encouraged by Patterson Medical’s solid sales growth, which is benefiting from the revenues generated by its branch office strategy and other growth initiatives implemented during the year.”

Wiltz added: “Based upon the progress posted by our three businesses in the fourth quarter, we are optimistic about Patterson’s prospects for fiscal 2008. We are forecasting earnings of $0.34 to $0.36 per diluted share for the first quarter of fiscal 2008 ending July 28, 2007, and for the full year, we are forecasting earnings of $1.73 to $1.77 per diluted share.”

Impact of Compensation Expense Under SFAS No. 123(R)

Net income and earnings per share excluding the impact of compensation expense under SFAS No. 123(R) are considered non-GAAP financial measures. The company adopted SFAS No. 123(R) on April 30, 2006 using the modified prospective method. Management believes that reporting net income and earnings per share excluding the impact of compensation expense under SFAS No. 123(R) provides useful supplemental information that may enhance investors’ overall understanding of the company’s current financial performance and may enhance the comparability of results against comparable periods. Net income and earnings per share excluding the impact of SFAS No. 123(R) are used by management internally to measure the company’s profitability and performance, but should not be considered as an alternative to, or a substitute for, GAAP financial measures. A reconciliation of net income and earnings per share with and without the impact of SFAS No. 123(R) is included as a table attached to this press release.

About Patterson Companies, Inc.

Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets.

Dental Market

As Patterson’s largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.

Veterinary Market

Webster Veterinary is the nation’s second largest distributor of consumable veterinary supplies, equipment and software, diagnostic products, vaccines and pharmaceuticals to companion-pet veterinary clinics.

Rehabilitation Market

Patterson Medical is the world’s leading distributor of rehabilitation supplies and non-wheelchair assistive patient products to the physical and occupational therapy markets. The unit’s global customer base includes hospitals, long-term care facilities, clinics and dealers.

#            #            #


This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond the Company’s ability to control. The Company cautions shareholders and prospective investors that the following factors, among others, may cause actual results to differ materially from those indicated by the forward-looking statements: competition within the dental, veterinary, and rehabilitative and assistive living supply industries; changes in the economics of dentistry, including reduced growth in expenditures by private dental insurance plans, the effects of economic conditions and the effects of healthcare reform, which may affect future per capita expenditures for dental services and the ability and willingness of dentists to invest in high-technology products; the effects of healthcare related legislation and regulation which may affect expenditures or reimbursements for rehabilitative and assistive products; changes in the economics of the veterinary supply market, including reduced growth in per capita expenditures for veterinary services and reduced growth in the number of households owning pets; the ability of the Company to maintain satisfactory relationships with its sales force; unforeseen operating risks; risks associated with the dependence on manufacturers of the Company’s products; and the ability of the Company to successfully integrate the recent acquisitions into its existing business. Forward-looking statements are qualified in their entirety by the cautionary language set forth in the Company’s filings with the Securities and Exchange Commission.

 

For additional information contact:  
R. Stephen Armstrong   Richard G. Cinquina
Executive Vice President & CFO   Equity Market Partners
651/686-1600   904/415-1415

Fourth Quarter Conference Call and Replay

Patterson’s fourth quarter earnings conference call will start at 10:00 a.m. Eastern today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com. Listeners should go to this website at least 15 minutes prior to the call to download and install any necessary audio software. The conference call will be archived on Patterson’s web site. A replay of the third quarter conference call can be heard through May 31, 2007 by dialing 1-303-590-3000 and providing the 11090468 confirmation code.


PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except for earnings per share)

(Unaudited)

 

     Three Months Ended     Twelve Months Ended  
     April 28,
2007
    April 29,
2006
    April 28,
2007
    April 29,
2006
 

Net sales

   $ 739,143     $ 695,177     $ 2,798,398     $ 2,615,123  

Gross profit

     260,563       247,002       968,872       914,429  

Operating expenses

     164,117       154,876       633,182       591,417  
                                

Operating income

     96,446       92,126       335,690       323,012  

Other expense, net

     (1,038 )     (1,361 )     (6,082 )     (6,039 )
                                

Income before taxes

     95,408       90,765       329,608       316,973  

Income taxes

     35,484       33,946       121,272       118,548  
                                

Net income

   $ 59,924     $ 56,819     $ 208,336     $ 198,425  
                                

Earnings per share:

        

Basic

   $ 0.44     $ 0.41     $ 1.52     $ 1.44  

Diluted

   $ 0.44     $ 0.41     $ 1.51     $ 1.43  

Shares:

        

Basic

     135,695       138,103       136,815       137,690  

Diluted

     136,612       139,294       137,769       139,234  

 

-more-


PATTERSON COMPANIES, INC.

RECONCILIATION OF IMPACT OF SFAS NO. 123(R) ON EARNINGS

AND FINANCIAL RATIOS

(In thousands, except for earnings per share)

(Unaudited)

 

     Three Months Ended    Twelve Months Ended
     April 28,
2007
   April 29,
2006
   April 28,
2007
   April 29,
2006

NET INCOME:

           

GAAP net income

   $ 59,924    $ 56,819    $ 208,336    $ 198,425

SFAS No. 123(R) expense, net of tax

     1,476      —        6,253      —  
                           

Non-GAAP net income

   $ 61,400    $ 56,819    $ 214,589    $ 198,425
                           

DILUTED EARNINGS PER SHARE:

           

GAAP diluted earnings per share

   $ 0.44    $ 0.41    $ 1.51    $ 1.43

SFAS No. 123(R) expense, net of tax

     0.01      —        0.05      —  
                           

Non-GAAP diluted earnings per share

   $ 0.45    $ 0.41    $ 1.56    $ 1.43
                           

 

     Three Months Ended     Twelve Months Ended  
  

April 28,

2007

    As reported
April 29,
2006
   

April 28,

2007

    As reported
April 29,
2006
 
     As reported     Excluding SFAS
No. 123(R)
      As reported     Excluding SFAS
No. 123(R)
   

Gross margin

   35.2 %   35.2 %   35.6 %   34.6 %   34.6 %   35.0 %

Operating expenses as a % of net sales

   22.2 %   21.9 %   22.3 %   22.6 %   22.3 %   22.6 %

Operating income as a % of net sales

   13.0 %   13.3 %   13.3 %   12.0 %   12.3 %   12.4 %

Effective tax rate

   37.2 %   36.9 %   37.4 %   36.8 %   36.4 %   37.4 %

Return on net sales

   8.1 %   8.3 %   8.2 %   7.4 %   7.7 %   7.6 %

 

-more-


PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

 

     April 28,
2007
   April 29,
2006
     (Unaudited)     

ASSETS

     

Current assets:

     

Cash and short-term investments

   $ 241,791    $ 224,392

Receivables, net

     361,401      350,299

Inventory

     250,207      244,709

Prepaid expenses and other current assets

     33,091      27,974
             

Total current assets

     886,490      847,374

Property and equipment, net

     131,952      141,541

Goodwill and other intangible assets

     762,930      764,214

Other

     158,948      158,589
             

Total Assets

   $ 1,940,320    $ 1,911,718
             

LIABILITIES AND STOCKHOLDERS’ EQUITY

     

Current liabilities:

     

Accounts payable

   $ 182,761    $ 173,957

Other accrued liabilities

     144,694      145,663

Current maturities of long-term debt

     50,014      90,027
             

Total current liabilities

     377,469      409,647

Long-term debt

     130,010      210,014

Other non-current liabilities

     53,627      49,536
             

Total liabilities

     561,106      669,197

Stockholders’ equity

     1,379,214      1,242,521
             

Total Liabilities and Stockholders’ Equity

   $ 1,940,320    $ 1,911,718
             

 

-more-


PATTERSON COMPANIES, INC.

SUPPLEMENTARY FINANCIAL DATA

(Dollars in thousands)

(Unaudited)

 

     Three Months Ended     Twelve Months Ended  
     April 28,
2007
    April 29,
2006
    April 28,
2007
    April 29,
2006
 

Consolidated Net Sales

        

Consumable and printed products

   $ 462,329     $ 438,371     $ 1,757,472     $ 1,633,544  

Equipment and software

     218,912       205,081       821,091       789,263  

Other

     57,902       51,725       219,835       192,316  
                                

Total

   $ 739,143     $ 695,177     $ 2,798,398     $ 2,615,123  
                                

Dental Supply

        

Consumable and printed products

   $ 301,930     $ 295,057     $ 1,154,422     $ 1,092,097  

Equipment and software

     188,828       182,394       714,343       703,252  

Other

     51,815       45,483       195,865       171,605  
                                

Total

   $ 542,573     $ 522,934     $ 2,064,630     $ 1,966,954  
                                

Rehabilitation Supply

        

Consumable and printed products

   $ 61,328     $ 53,720     $ 241,112     $ 219,080  

Equipment

     21,473       17,308       77,252       68,618  

Other

     4,082       3,888       15,978       14,323  
                                

Total

   $ 86,883     $ 74,916     $ 334,342     $ 302,021  
                                

Veterinary Supply

        

Consumable and printed products

   $ 99,071     $ 89,594     $ 361,938     $ 322,367  

Equipment and software

     8,611       5,379       29,496       17,393  

Other

     2,005       2,354       7,992       6,388  
                                

Total

   $ 109,687     $ 97,327     $ 399,426     $ 346,148  
                                

Other (Expense) Income, net

        

Interest income

   $ 2,135     $ 1,700     $ 8,070     $ 6,381  

Interest expense

     (3,228 )     (3,719 )     (14,230 )     (13,375 )

Other

     55       658       78       955  
                                
   $ (1,038 )   $ (1,361 )   $ (6,082 )   $ (6,039 )
                                

 

-more-


PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

     Twelve Months Ended  
     April 28,
2007
    April 29,
2006
 

Operating activities:

    

Net income

   $ 208,336     $ 198,425  

Depreciation & amortization

     25,501       23,676  

Share-based compensation

     7,757       750  

Change in assets and liabilities, net of acquired

     1,911       (58,893 )
                

Net cash provided by operating activities

     243,505       163,958  

Investing activities:

    

Additions to property and equipment, net of disposals

     (19,507 )     (49,153 )

Proceeds from disposals of property and equipment

     9,163       —    

Acquisitions

     (12,665 )     (39,228 )

Distribution agreement

     —         (100,000 )

Sale of investments, net

     —         13,382  
                

Net cash used in investing activities

     (23,009 )     (174,999 )

Net cash (used in) provided by financing activities

     (203,097 )     2,884  
                

Net increase (decrease) in cash and cash equivalents

   $ 17,399     $ (8,157 )